Introduction / Background
SEMAX (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide first developed as a structural analogue of the adrenocorticotropic hormone (ACTH) fragment ACTH(4–7). Unlike its parent sequence, SEMAX has been engineered with a C-terminal Pro-Gly-Pro extension that confers greater metabolic stability against enzymatic degradation, making it a useful tool compound in laboratory settings.
Researchers have long been interested in neuropeptides as molecular probes for investigating cellular signalling networks. SEMAX occupies a notable position in this landscape due to its reported interactions with neurotrophic factor pathways, particularly those involving brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). These properties have driven a steady body of in-vitro and preclinical investigation over several decades.
Mechanism of Action in Preclinical Research
In-vitro cellular assays and preclinical rodent models have pointed to several interconnected mechanisms through which SEMAX may exert its effects at the molecular level:
-
Melanocortin receptor engagement: SEMAX is structurally derived from the melanocortin sequence and has been shown to interact with melanocortin receptor subtypes (particularly MC4R) in cell-based binding assays, influencing downstream cyclic AMP (cAMP) signalling cascades.
-
Neurotrophin upregulation: Cell culture studies have observed that SEMAX can modulate the expression of BDNF and its high-affinity receptor TrkB, as well as components of the NGF signalling axis. This makes it a valuable probe for studying neurotrophin-mediated intracellular pathways.
-
Nitric oxide modulation: Some in-vitro work has implicated SEMAX in the regulation of nitric oxide synthase (NOS) activity within neural cell lines, suggesting potential utility for investigating oxidative and nitrergic signalling.
-
Gene expression profiling: Transcriptomic studies conducted in cell culture have identified SEMAX as a modulator of immediate-early gene expression, including c-Fos and c-Jun, offering a window into activity-dependent transcriptional regulation.
The multi-target profile of SEMAX makes it a versatile research tool when investigators wish to interrogate the crosstalk between neuropeptide receptors, growth factor signalling, and transcriptional responses within a single experimental framework.
Research Applications
Laboratory groups have applied SEMAX across a variety of in-vitro research contexts, including:
-
Neuroprotection modelling: Primary neuronal cultures and immortalised cell lines (e.g., SH-SY5Y, PC12) have been exposed to SEMAX to study its effects on cell viability under conditions of oxidative stress or excitotoxic insult, providing mechanistic insight into peptide-mediated cytoprotective signalling.
-
Neuroplasticity and synaptogenesis studies: Researchers have used SEMAX to probe synaptic protein expression (e.g., PSD-95, synapsin) in cortical and hippocampal cell cultures, contributing to understanding of structural plasticity at the molecular level.
-
Inflammatory signalling panels: Cytokine array experiments in glial cell cultures have employed SEMAX to assess modulation of pro- and anti-inflammatory mediators, including IL-1β, TNF-α, and IL-10.
-
Receptor binding and internalisation assays: Radio-ligand and fluorescent-tagging approaches have been used to characterise SEMAX's binding kinetics and receptor trafficking profiles at melanocortin receptor-expressing cell lines.
Laboratory Handling & Reconstitution
SEMAX is typically supplied as a lyophilised white powder and should be stored at −20 °C in a desiccated environment, protected from light. For working solutions, bacteriostatic water (BAC water) or sterile phosphate-buffered saline (PBS) are appropriate reconstitution vehicles for most in-vitro applications.
General reconstitution guidance (example: 5 mg vial):
| Target Concentration | Volume of BAC Water (1 mg/mL) | Volume of BAC Water (2 mg/mL) | Volume of BAC Water (5 mg/mL) |
|---|---|---|---|
| 5 mg vial | Add 5.0 mL | Add 2.5 mL | Add 1.0 mL |
| 2 mg vial | Add 2.0 mL | Add 1.0 mL | Add 0.4 mL |
| 10 mg vial | Add 10.0 mL | Add 5.0 mL | Add 2.0 mL |
Aliquot reconstituted stock solutions into low-bind microcentrifuge tubes and store at −80 °C to minimise freeze-thaw degradation. Avoid repeated freeze-thaw cycles; ideally limit to no more than two per aliquot. Working dilutions for cell-based assays should be prepared fresh in appropriate culture media immediately prior to use.
Safe Handling Notes
While SEMAX does not carry acute chemical hazards under standard laboratory classification, good practice dictates adherence to general laboratory safety protocols:
- Wear appropriate PPE including nitrile gloves, eye protection, and a laboratory coat when handling reconstituted solutions.
- Work within a certified biological safety cabinet when preparing solutions for sterile cell culture applications.
- Dispose of all peptide-containing waste in accordance with your institution's chemical waste disposal policy.
- Consult the supplier's Safety Data Sheet (SDS) before handling and ensure colleagues are briefed on the compound's research-only status.
- Do not handle this compound outside of a properly equipped research laboratory environment.
All experimental protocols should be reviewed and approved by the relevant institutional safety or ethics committee appropriate to the scope of the research.
For laboratory research use only. Not for human or animal consumption.